Target intelligence / Profile preview

Dopaminergic Neurons in the Nigrostriatal Pathway

01

Overview

Dopaminergic neurons are cells that produce and release dopamine, and the nigrostriatal pathway is the neural pathway connecting the substantia nigra pars compacta to the striatum. This query presents a conceptual issue as it describes a neuronal population and neural circuit, not a discrete therapeutic target molecule or receptor suitable for drug development. While these neurons are critically involved in motor control, they are cellular structures rather than individual receptor, enzyme, or transporter molecules that can be directly targeted by drugs. The substantia nigra pars compacta is the specific brain region containing the dopaminergic neurons that form the nigrostriatal pathway. These neurons project dopaminergically to the striatum via the nigrostriatal pathway, where dopamine acts on D1 and D2 dopamine receptors expressed on striatal neurons. The pathway is clinically significant because loss of dopaminergic neurons in this region causes Parkinson's disease. Actual therapeutic targets related to this system would be specific molecular entities such as dopamine receptors, the dopamine transporter, or dopamine itself.

Other names
Nigrostriatal dopaminergic systemNigrostriatal pathway dopaminergic neurons
02

Biological functions

Produce and release dopamineForm the neural pathway connecting the substantia nigra pars compacta to the striatumCritically involved in motor control
03

Disease associations

Loss of dopaminergic neurons in this pathway causes Parkinson's disease

Beyond the preview

Go deeper on Dopaminergic Neurons in the Nigrostriatal Pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopaminergic Neurons in the Nigrostriatal Pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call